This inventor holds 3 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2013-2015.
Company Filing History:
Years Active: 2013-2015
Title: Masatoshi Murakata: Innovator in Spiroketal and Coumarin Derivatives
Introduction
Masatoshi Murakata is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of chemistry, particularly in the development of spiroketal and coumarin derivatives. With a total of 3 patents to his name, Murakata continues to push the boundaries of innovation in his area of expertise.
Latest Patents
Murakata's latest patents include a process for preparing spiroketal derivatives and a novel method for producing coumarin derivatives. The first patent outlines a method that utilizes an intermediate represented by Formula (VI), which can be produced from dihalobenzene derivatives in a one-pot reaction. The second patent provides a method for producing a compound represented by a general formula (VII) or a pharmaceutically acceptable salt thereof. This method involves various groups and atoms, showcasing the complexity and innovation behind his work.
Career Highlights
Masatoshi Murakata is currently associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. His work at Chugai has allowed him to focus on the synthesis of novel chemical compounds that have potential applications in medicine and other fields.
Collaborations
Throughout his career, Murakata has collaborated with notable colleagues, including Takuma Ikeda and Keisuke Yamamoto. These collaborations have further enriched his research and contributed to the advancement of their shared goals in the field of chemistry.
Conclusion
Masatoshi Murakata stands out as an innovative inventor whose work in spiroketal and coumarin derivatives has the potential to impact various industries. His dedication to research and development continues to inspire future innovations in chemistry.